192 related articles for article (PubMed ID: 33099068)
41. Pyroptosis is related to immune infiltration and predictive for survival of colon adenocarcinoma patients.
Lu H; Sun Y; Zhu Z; Yao J; Xu H; Huang R; Huang B
Sci Rep; 2022 Jun; 12(1):9233. PubMed ID: 35655081
[TBL] [Abstract][Full Text] [Related]
42. Prognostic Biomarker SLCO4A1 Is Correlated with Tumor Immune Infiltration in Colon Adenocarcinoma.
Chen X; Yi G; Zhou Y; Hu W; Xi L; Han W; Wang F
Mediators Inflamm; 2023; 2023():4926474. PubMed ID: 37124063
[TBL] [Abstract][Full Text] [Related]
43. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19.
Ahmadi M; Pashangzadeh S; Mousavi P; Saffarzadeh N; Amin Habibi M; Hajiesmaeili F; Rezaei N
Int Immunopharmacol; 2021 Jun; 95():107568. PubMed ID: 33765612
[TBL] [Abstract][Full Text] [Related]
44. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
45. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
46. Identification of survival-related alternative splicing signatures in acute myeloid leukemia.
Zhang B; Yang L; Wang X; Fu D
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178
[TBL] [Abstract][Full Text] [Related]
47. Exploring immune-related signatures for predicting immunotherapeutic responsiveness, prognosis, and diagnosis of patients with colon cancer.
Cao L; Ba Y; Yang J; Zhang H
Aging (Albany NY); 2022 Jun; 14(12):5131-5152. PubMed ID: 35748788
[TBL] [Abstract][Full Text] [Related]
48. Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma.
Liang W; Sun F
Front Endocrinol (Lausanne); 2021; 12():538364. PubMed ID: 33776902
[TBL] [Abstract][Full Text] [Related]
49. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
Zheng X; Liu X; Zheng H; Wang H; Hong D
Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
[TBL] [Abstract][Full Text] [Related]
50. Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer.
Zhou R; Zhang J; Zeng D; Sun H; Rong X; Shi M; Bin J; Liao Y; Liao W
Cancer Immunol Immunother; 2019 Mar; 68(3):433-442. PubMed ID: 30564892
[TBL] [Abstract][Full Text] [Related]
51. Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy.
Xu M; Chang J; Wang W; Wang X; Wang X; Weng W; Tan C; Zhang M; Ni S; Wang L; Huang Z; Deng Z; Li W; Huang D; Sheng W
Front Immunol; 2022; 13():934083. PubMed ID: 35967414
[TBL] [Abstract][Full Text] [Related]
52. Identification of immune-related genes as prognostic factors in bladder cancer.
Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
[TBL] [Abstract][Full Text] [Related]
53. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
[TBL] [Abstract][Full Text] [Related]
54. Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma.
Wu S; Gong Y; Chen J; Zhao X; Qing H; Dong Y; Li S; Li J; Wang Z
Biol Direct; 2022 Jul; 17(1):19. PubMed ID: 35902970
[TBL] [Abstract][Full Text] [Related]
55. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
Ruan GT; Wang S; Zhu LC; Liao XW; Wang XK; Liao C; Yan L; Xie HL; Gong YZ; Gan JL; Gao F
Aging (Albany NY); 2021 Apr; 13(9):12565-12586. PubMed ID: 33909599
[TBL] [Abstract][Full Text] [Related]
56. Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma.
Yuemaier M; Zhou Z; Zhou Y; Wu C; Li F; Liang X; Kang H; Shen D; Gao F; Lin J
Med Sci Monit; 2020 Nov; 26():e927073. PubMed ID: 33161410
[TBL] [Abstract][Full Text] [Related]
57. Using the TCGA Database to Predict and Analyze Tumor Microenvironment Genes Related to Poor Prognosis of Colon Cancer.
Chen S; Yida L; Chen B; Xiong M
Med Sci Monit; 2020 Jun; 26():e923707. PubMed ID: 32555128
[TBL] [Abstract][Full Text] [Related]
58. Tumor microenvironment-associated gene C3 can predict the prognosis of colorectal adenocarcinoma: a study based on TCGA.
Liu Y; Wang X
Clin Transl Oncol; 2021 Sep; 23(9):1923-1933. PubMed ID: 33765255
[TBL] [Abstract][Full Text] [Related]
59. Construction of a Risk Model for Colon Cancer Prognosis Based on Ubiquitin-Related Genes.
Hu B; Chen Z; Yao F; Li B
Turk J Gastroenterol; 2023 May; 34(5):449-456. PubMed ID: 37158531
[TBL] [Abstract][Full Text] [Related]
60. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]